Physician profile
Lan Wu
NPI 1588117766
$2,280.68
in general payments reported to CMS, 2019-2025
12 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $367 · 2023: $466 · 2024: $822 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $764.32 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $675.90 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $187.12 | 2023-2025 | Zerbaxa, Dificid, Zinplava |
| Pfizer INC. | $181.58 | 2021-2025 | |
| Gilead Sciences, INC. | $162.99 | 2022-2024 | Biktarvy |
| Ucb, INC. | $84.38 | 2024-2025 | Briviact |
| Smith+Nephew, INC. | $60.66 | 2021-2025 | Collagenase Santyl |
| Novartis Pharmaceuticals Corporation | $49.70 | 2024 | |
| Mylan Specialty L.P. | $36.13 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $35.16 | 2023 | Lokelma |
| Fisher & Paykel Healthcare INC | $25.45 | 2024 | Fisher & Paykel Healthcare |
| Vapotherm INC | $17.29 | 2024 | Vapotherm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lan Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.